This HTML5 document contains 62 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
n5http://dx.doi.org/10.3390/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q100410115
rdf:type
wikibase:Item
schema:description
article scientifique publié en 2020 scientific article published on 29 September 2020 наукова стаття, опублікована 29 вересня 2020 artículu científicu espublizáu en setiembre de 2020 wetenschappelijk artikel
p:P577
wds:Q100410115-3BE36496-E8FA-4CCE-A610-25C712639619
wdt:P577
2020-09-29T00:00:00Z
p:P2093
wds:Q100410115-985A807F-F3A5-4D54-BD53-5B8B8413E9A8
wdt:P2093
Charlotte Martin
rdfs:label
Anti-human PD-L1 Nanobody for Immuno-PET Imaging: Validation of a Conjugation Strategy for Clinical Translation Anti-human PD-L1 Nanobody for Immuno-PET Imaging: Validation of a Conjugation Strategy for Clinical Translation
skos:prefLabel
Anti-human PD-L1 Nanobody for Immuno-PET Imaging: Validation of a Conjugation Strategy for Clinical Translation Anti-human PD-L1 Nanobody for Immuno-PET Imaging: Validation of a Conjugation Strategy for Clinical Translation
schema:name
Anti-human PD-L1 Nanobody for Immuno-PET Imaging: Validation of a Conjugation Strategy for Clinical Translation Anti-human PD-L1 Nanobody for Immuno-PET Imaging: Validation of a Conjugation Strategy for Clinical Translation
p:P50
wds:Q100410115-1F9AFA35-EB96-4E8F-85EC-6F27ABEE6E66 wds:Q100410115-2077D7F5-7581-4B18-8B25-FF70A1339079 wds:Q100410115-2ED82C8B-7605-4341-B5CE-2F01A0AF7B9E wds:Q100410115-3E3172B9-38C2-42EF-9BDE-DD62B9F5FE2D wds:Q100410115-4DBF8F67-1D76-4888-9378-0F8A777E2D30 wds:Q100410115-80AAB0AA-1932-4F36-85A7-E305798E2964 wds:Q100410115-94D4D709-D5EE-4DE4-9240-0641AF546D49 wds:Q100410115-96F3D4CB-511E-4507-A8DC-BA8FB7BF82A1 wds:Q100410115-9A50F70A-378F-4FBA-899B-425362280BFB wds:Q100410115-A3DA962E-1CA1-4F8C-9676-DD7B167BA788 wds:Q100410115-B61E527B-C247-48E5-AF76-297C12F18679 wds:Q100410115-D95BDDC4-7DAB-447F-8DA9-C18A6295A0A3 wds:Q100410115-FFF90871-42FB-4BB0-9D7D-190B494FBB94
wdt:P50
wd:Q38326061 wd:Q114563798 wd:Q88939350 wd:Q87933935 wd:Q73399920 wd:Q88917814 wd:Q84779635 wd:Q35704584 wd:Q39183342 wd:Q89376278 wd:Q91172796 wd:Q63980840 wd:Q57036090
p:P1476
wds:Q100410115-081A8E2C-61DF-4C7D-A3DF-A1B57AC8F4DD
wdt:P1476
Anti-human PD-L1 Nanobody for Immuno-PET Imaging: Validation of a Conjugation Strategy for Clinical Translation
p:P31
wds:Q100410115-66406AB2-87CB-408E-A0D9-D855D4BA3128
wdt:P31
wd:Q13442814
p:P698
wds:Q100410115-B433CDE7-08F5-4172-B94A-10C85263AE1A
wdtn:P698
n11:33003481
wdt:P698
33003481
p:P1433
wds:Q100410115-EEAE08BD-957A-4512-A3B2-0781D8859EDA
wdt:P1433
wd:Q23929963
p:P433
wds:Q100410115-8B1F2F42-B5C6-4050-822B-776F93C66837
p:P478
wds:Q100410115-1AE750E8-E84F-4FC7-984E-A2BC6A6A543C
wdt:P433
10
wdt:P478
10
p:P356
wds:Q100410115-CE10564F-7E59-467E-95CC-58968A7B899C
wdtn:P356
n5:BIOM10101388
wdt:P356
10.3390/BIOM10101388
p:P275
wds:Q100410115-6baf1869-a9a1-4ec1-ab8d-c10f544a5d6a
p:P6216
wds:Q100410115-c581494f-d5d6-4009-bbf4-fb17d6de537c
wdt:P275
wd:Q20007257
wdt:P6216
wd:Q50423863